Possibly contaminated Gerber infant formula sent to Alabama after recall

Gerber Good Start SootheProTM Powdered Infant Formula had a possible presence of Cronobacter sakazakii, which can cause serious or deadly infections.

More News

Duchenne Muscular Dystrophy Treatment Narrowly Captures Support of FDA Advisors

FDA advisors narrowly supported accelerated approval for Sarepta Therapeutics' investigational gene therapy for Duchenne muscular dystrophy (DMD) on Friday. In a 8-to-6 vote, the agency's Cellular, Tissue,

Austin doctors who treated trans kids leaving Dell Children’s clinic after AG Paxton ...

Dell Children’s said in a statement Saturday that while its adolescent medicine clinic remains open, “the physicians who previously staffed the clinic will be departing.” Parents said they were told about the doctors’ departures just hours after Attorney General Ken Paxton announced an investigation into “potentially illegal” activity at Dell Children’s.

Cancer drugs among top 5 most affected by shortages in the US

The fact that we have this many chemo drugs in shortage is really concerning,” said Michael Ganio, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists.

Older women may need be better treatments for clogged arteries

Researchers say older women who have atherosclerosis, a clogging of the arteries, are at higher risk of a heart attack or other cardiovascular event than men in the same age group

The health impacts of incarceration don’t end after release

Thousands of people are released from prisons and jails every year with conditions such as cancer, heart disease, and infectious diseases.

NOT REAL NEWS: A look at what didn't happen this week

The article is based on real remarks Clinton made at a recent conference on global health, where she spoke about the Clinton Health Access Initiative, a nonprofit founded by her father, and a new global initiative it’s working with called “ The Big Catch-Up.

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 billion a year ...

Wide coverage of Alzheimer's drug Leqembi would raise future costs for the U.S. Medicare health plan by $2 billion to $5 billion a year, according to a study led by researchers at the University of California,

.

.